Skip to main content
. 2024 May 5;12(5):500. doi: 10.3390/vaccines12050500

Figure A6.

Figure A6

Vaccine efficacy (VE) for respiratory syncytial virus (RSV) vaccines in older adults (age ≥ 70/75 years) with acute respiratory infection (ARI, I2 22.1%, 95% CI 0.0 to 91.9; tau2 0.079, 95% CI 0.0 to 10.349; Q = 2.57, p = 0.277) [51,52,82].